Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression
- 8 March 2008
- journal article
- review article
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 197 (2) , 75-82
- https://doi.org/10.1007/s00430-008-0087-0
Abstract
The human cytomegalovirus (HCMV) is a relevant pathogen in patients with immunosuppressive therapy; however, reactivation and subsequent recurrence occurs also in individuals without canonical immunosuppression as e.g., in patients with septic shock. Analyzing the impact of NK- and T-cell immunity on the natural course of HCMV infection in patients with septic shock, it became clear that the presence of HCMV reactive T-helper cells did not prevent the development of reactivation but, the control of active infection was achieved mostly by specific T-cells. NK-cells seemed to be dispensable for clearance of active infection in this patient group with long-lasting NK-cell anergy.Keywords
This publication has 57 references indexed in Scilit:
- Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral propertiesMolecular Immunology, 2007
- CD8 T Cells Control Cytomegalovirus Latency by Epitope-Specific Sensing of Transcriptional ReactivationJournal of Virology, 2006
- Active Cytomegalovirus Infection in Patients with Septic ShockEmerging Infectious Diseases, 2006
- Lipopolysaccharide, Tumor Necrosis Factor Alpha, or Interleukin-1β Triggers Reactivation of Latent Cytomegalovirus in Immunocompetent MiceJournal of Virology, 2006
- Cytomegalovirus infection in burns: a reviewJournal of Medical Microbiology, 2006
- Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantationJournal of Medical Virology, 2006
- Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplantsBlood, 2004
- Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failureThe American Journal of Cardiology, 2004
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell ClonesScience, 1992